Charmacy Pharmaceutical Co logo

2289 - Charmacy Pharmaceutical Co Share Price

HK$4.52 -0.0  -0.2%

Last Trade - 3:27am

Consumer Defensives
Micro Cap
Market Cap £47.2m
Enterprise Value £92.3m
Revenue £415.7m
Position in Universe 4069th / 5960
Unlock 2289 Revenue
Relative Strength (%)
1m -12.4%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -40.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
3,014 3,397 3,670 4,096 3,935 3,493 6,647 +3.0%
+64.0 -27.7 +62.7 -19.3 +3.5 -12.3 +121.9
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, CharmacyPharmaceutical Co Ltd revenues increased 9% to RMB1.86B.Net income decreased 27% to RMB30.9M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net income was offsetby Depreciation and amortization increase of 88% to RMB8.8M(expense), Impairment loss of credits increase from RMB586K(income) to RMB3.1M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


2289 Revenue Unlock 2289 Revenue

Net Income

2289 Net Income Unlock 2289 Revenue

Normalised EPS

2289 Normalised EPS Unlock 2289 Revenue

PE Ratio Range

2289 PE Ratio Range Unlock 2289 Revenue

Dividend Yield Range

2289 Dividend Yield Range Unlock 2289 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
2289 EPS Forecasts Unlock 2289 Revenue
Profile Summary

Charmacy Pharmaceutical Co., Ltd. is principally engaged in pharmaceutical products distribution in the People’s Republic of China (the PRC). The products also include healthcare medicine, traditional Chinese drinking tablets, traditional Chinese medicine and medical equipment. Through its subsidiaries, the Company is also engaged in the trading of pharmaceutical products and provision of related services.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated February 18, 1984
Public Since December 14, 2015
No. of Shareholders: n/a
No. of Employees: 790
Sector Consumer Defensives
Industry Food & Drug Retailing
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 108,000,000
Free Float (0.0%)
Eligible for
2289 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 2289
Upcoming Events for 2289
Frequently Asked Questions for Charmacy Pharmaceutical Co
What is the Charmacy Pharmaceutical Co share price?

As of 3:27am, shares in Charmacy Pharmaceutical Co are trading at HK$4.52, giving the company a market capitalisation of £47.2m. This share price information is delayed by 15 minutes.

How has the Charmacy Pharmaceutical Co share price performed this year?

Shares in Charmacy Pharmaceutical Co are currently trading at HK$4.52 and the price has moved by -38.7% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Charmacy Pharmaceutical Co price has moved by -46.92% over the past year.

What are the analyst and broker recommendations for Charmacy Pharmaceutical Co?

Of the analysts with advisory recommendations for Charmacy Pharmaceutical Co, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Charmacy Pharmaceutical Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Charmacy Pharmaceutical Co next release its financial results?

Charmacy Pharmaceutical Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Charmacy Pharmaceutical Co dividend yield?

The Charmacy Pharmaceutical Co dividend yield is 5.09% based on the trailing twelve month period.

Does Charmacy Pharmaceutical Co pay a dividend?

Last year, Charmacy Pharmaceutical Co paid a total dividend of 0.2, and it currently has a trailing dividend yield of 5.09%. Looking ahead, Charmacy Pharmaceutical Co has not announced an ex-dividend date yet.

When does Charmacy Pharmaceutical Co next pay dividends?

Charmacy Pharmaceutical Co has yet to annouce their ex-dividend date. The historic dividend yield on Charmacy Pharmaceutical Co shares is currently 5.09%.

How do I buy Charmacy Pharmaceutical Co shares?

To buy shares in Charmacy Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Charmacy Pharmaceutical Co?

Shares in Charmacy Pharmaceutical Co are currently trading at HK$4.52, giving the company a market capitalisation of £47.2m.

Where are Charmacy Pharmaceutical Co shares listed? Where are Charmacy Pharmaceutical Co shares listed?

Here are the trading details for Charmacy Pharmaceutical Co:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 2289
What kind of share is Charmacy Pharmaceutical Co?

Based on an overall assessment of its quality, value and momentum, Charmacy Pharmaceutical Co is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Charmacy Pharmaceutical Co share price forecast 2020?

Shares in Charmacy Pharmaceutical Co are currently priced at HK$4.52. At that level they are trading at 0.129% discount to the analyst consensus target price of 0.00.

Analysts covering Charmacy Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of 0.871 for the next financial year.

How can I tell whether the Charmacy Pharmaceutical Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Charmacy Pharmaceutical Co. Over the past six months, the relative strength of its shares against the market has been -37.98%. At the current price of HK$4.52, shares in Charmacy Pharmaceutical Co are trading at -20.89% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Charmacy Pharmaceutical Co PE Ratio?

The Charmacy Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 13.3. The shares are currently trading at HK$4.52.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Charmacy Pharmaceutical Co?

Charmacy Pharmaceutical Co's management team is headed by:

Chuanglong Yao - CHM
Yuyan Zheng - CMO
Jianbo Fan - CTO
Zhixiong Lin - CFO
Chi Wai Wan - NID
Tao Zhou - NID
Jian Guan - NID
Zhijie Lin - OTH
Weisheng Li - NED
Who are the major shareholders of Charmacy Pharmaceutical Co?

Here are the top five shareholders of Charmacy Pharmaceutical Co based on the size of their shareholding:

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Corporation
Percentage owned: 28.24% (7.91m shares)
RAYS Capital Partners Limited Investment Advisor
Percentage owned: 19.76% (5.53m shares)
Wang (Yonghui) Individual Investor
Percentage owned: 12.46% (3.49m shares)
Kingworld Medicines Group Limited Corporation
Percentage owned: 8.22% (2.30m shares)
Similar to 2289
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.